CCR5 interactions with the variable 3 loop of gp120

被引:0
|
作者
Kelby B. Napier
Zi-xuan Wang
Stephen C. Peiper
John O. Trent
机构
[1] University of Louisville,Department of Biochemistry and Molecular Biology
[2] Medical College of Georgia,Department of Pathology and Institute of Molecular Medicine and Genetics
[3] University of Louisville,J. G. Brown Modeling Facility, Brown Cancer Center
[4] University of Louisville,Department of Medicine
来源
关键词
HIV-1; CCR5; Molecular modeling; gp120; V3 loop;
D O I
暂无
中图分类号
学科分类号
摘要
The G-protein coupled receptor CCR5 functions pathologically as the primary co-receptor for macrophage tropic (R5) strains of HIV-1. The interactions responsible for co-receptor activity are unknown. Molecular-dynamics simulations of the extracellular and adjacent transmembrane domains of CCR5 were performed with explicit solvation utilizing a rhodopsin-based homology model. The functional unit of co-receptor binding was constructed via docking and molecular-dynamics simulation of CCR5 and the variable 3 loop of gp120, which is a dominant determinant of co-receptor utilization. The variable 3 loop was demonstrated to interact primarily with the amino terminus and the second extracellular loop of CCR5, providing novel structural information regarding the co-receptor-binding site. Alanine mutants that alter chemokine binding and co-receptor activity were examined. Molecular-dynamics simulations with and without the variable 3 loop of gp120 were able to rationalize the activities of these mutants successfully, providing support for the proposed model. Based on these results, the global complex of CCR5, gp120 including the V3 loop and CD4, was investigated. The utilization of computational analysis, in combination with molecular biological data, provides a powerful approach for understanding the use of CCR5 as a co-receptor by HIV-1.
引用
收藏
页码:29 / 41
页数:12
相关论文
共 50 条
  • [41] Defining specific residue-to-residue interactions between the gp120 bridging sheet and the N-terminal segment of CCR5: applications of transferred NOE NMR
    Srivastava, Gautam
    Moseri, Adi
    Kessler, Naama
    Arshava, Boris
    Naider, Fred
    Anglister, Jacob
    FEBS JOURNAL, 2018, 285 (22) : 4296 - 4310
  • [42] A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs
    de Parseval, A
    Bobardt, MD
    Chatterji, A
    Chatterji, U
    Elder, JH
    David, G
    Zolla-Pazner, S
    Farzan, M
    Lee, TH
    Gallay, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) : 39493 - 39504
  • [43] Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
    Dragic, T
    Trkola, A
    Lin, SW
    Nagashima, KA
    Kajumo, F
    Zhao, L
    Olson, WC
    Wu, LJ
    Mackay, CR
    Allaway, GP
    Sakmar, TP
    Moore, JP
    Maddon, PJ
    JOURNAL OF VIROLOGY, 1998, 72 (01) : 279 - 285
  • [44] CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5
    Raja, A
    Venturi, M
    Kwong, P
    Sodroski, J
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 713 - 718
  • [45] Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
    Huang, Chih-chin
    Lam, Son N.
    Acharya, Priyamvada
    Tang, Min
    Xiang, Shi-Hua
    Hussan, Syed Shahzad-ul
    Stanfield, Robyn L.
    Robinson, James
    Sodroski, Joseph
    Wilson, Ian A.
    Wyatt, Richard
    Bewley, Carole A.
    Kwong, Peter D.
    SCIENCE, 2007, 317 (5846) : 1930 - 1934
  • [46] NMR structural analysis of the HIV-1 GP120 V3 - CCR5 co-receptor N-terminal interaction
    Galanakis, P. A.
    Kandias, N.
    Spyroulias, G. A.
    Sioumpara, M.
    Morikis, D.
    Rizos, A.
    Krambovitis, E.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 196 - 196
  • [47] 利用定点突变研究CCR5膜外襻上与HIV gp120结合的关键残基
    道书艳
    郭葆玉
    卞广兴
    第二军医大学学报, 2006, (01) : 68 - 70
  • [48] An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations
    Platt, Emily J.
    Durnin, James P.
    Shinde, Ujwal
    Kabat, David
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 374 (01) : 64 - 79
  • [49] Modification of the CCR5 binding site by mutations in gp120 influence drug susceptibility and viral infectivity in one subject with clinical resistance to vicriviroc
    Ogert, R. A.
    Hou, Y.
    Ba, L.
    Buontempo, C.
    Murgolo, N.
    Qiu, P.
    Duca, J.
    Strizki, J.
    Ralston, R.
    Howe, J. A.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A18 - A18
  • [50] Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage
    Shah, M
    Smit, TK
    Morgello, S
    Tourtellotte, W
    Gelman, B
    Brew, BJ
    Saksena, NK
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (02) : 177 - 181